| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2234* | 2021 |
| Nonbiopsy diagnosis of cardiac transthyretin amyloidosis JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ... Circulation 133 (24), 2404-2412, 2016 | 1924 | 2016 |
| Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or … F Grothues, GC Smith, JCC Moon, NG Bellenger, P Collins, HU Klein, ... The American journal of cardiology 90 (1), 29-34, 2002 | 1743 | 2002 |
| Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic … DR Messroghli, JC Moon, VM Ferreira, L Grosse-Wortmann, T He, ... Journal of Cardiovascular Magnetic Resonance 19 (1), 75, 2016 | 1651 | 2016 |
| Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance JA McCrohon, JCC Moon, SK Prasad, WJ McKenna, CH Lorenz, ... Circulation 108 (1), 54-59, 2003 | 1411 | 2003 |
| Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of … JC Moon, DR Messroghli, P Kellman, SK Piechnik, MD Robson, ... Journal of Cardiovascular Magnetic Resonance 15 (1), 92, 2013 | 1185 | 2013 |
| Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC … YM Pinto, PM Elliott, E Arbustini, Y Adler, A Anastasakis, M Böhm, ... European heart journal 37 (23), 1850-1858, 2016 | 1138 | 2016 |
| Cardiovascular magnetic resonance in cardiac amyloidosis AM Maceira, J Joshi, SK Prasad, JC Moon, E Perugini, I Harding, ... Circulation 111 (2), 186-193, 2005 | 1138 | 2005 |
| Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans AS Flett, MP Hayward, MT Ashworth, MS Hansen, AM Taylor, PM Elliott, ... Circulation 122 (2), 138-144, 2010 | 1051 | 2010 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 1008 | 2022 |
| Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance JCC Moon, WJ McKenna, JA McCrohon, PM Elliott, GC Smith, DJ Pennell Journal of the American College of Cardiology 41 (9), 1561-1567, 2003 | 955 | 2003 |
| Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy R O'Hanlon, A Grasso, M Roughton, JC Moon, S Clark, R Wage, J Webb, ... Journal of the American College of Cardiology 56 (11), 867-874, 2010 | 951 | 2010 |
| Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance F Grothues, JC Moon, NG Bellenger, GS Smith, HU Klein, DJ Pennell American heart journal 147 (2), 218-223, 2004 | 932 | 2004 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 842 | 2021 |
| The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy JCC Moon, E Reed, MN Sheppard, AG Elkington, SY Ho, M Burke, ... Journal of the American College of Cardiology 43 (12), 2260-2264, 2004 | 811 | 2004 |
| ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of … S Dorbala, Y Ando, S Bokhari, A Dispenzieri, RH Falk, VA Ferrari, ... Circulation: Cardiovascular Imaging 14 (7), e000029, 2021 | 778* | 2021 |
| Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis TD Karamitsos, SK Piechnik, SM Banypersad, M Fontana, NB Ntusi, ... JACC: Cardiovascular Imaging 6 (4), 488-497, 2013 | 756 | 2013 |
| Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance AS Flett, J Hasleton, C Cook, D Hausenloy, G Quarta, C Ariti, ... JACC: cardiovascular imaging 4 (2), 150-156, 2011 | 745 | 2011 |
| Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome SV Babu-Narayan, PJ Kilner, W Li, JC Moon, O Goktekin, PA Davlouros, ... Circulation 113 (3), 405-413, 2006 | 660 | 2006 |
| Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow … PA Davlouros, PJ Kilner, TS Hornung, W Li, JM Francis, JCC Moon, ... Journal of the American College of Cardiology 40 (11), 2044-2052, 2002 | 633 | 2002 |
Thomas A TreibelAssociate Professor in Cardiology, UCL, Barts Heart Centre, QMULDirección de correo verificada de ucl.ac.uk
